News

Regeneron's weight-loss drug helps patients on Wegovy preserve muscle
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
Regeneron Pharmaceuticals, Inc. (REGN)’s Weight-Loss Drug Aids Muscle Preservation in Wegovy Users
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on Monday that its experimental drug, when combined with Novo ...
PharmExec5d
Regeneron’s Semaglutide Plus Trevogrumab Combo Demonstrates Superior Fat Loss with Reduced Muscle Wasting in Obesity Trial
Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...
BioSpace6d
Amid Rough Waters, Regeneron Puts Nearly $2B on the Line For Chinese Obesity Drug
Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.
Investing6d
Semaglutide combination may protect muscle in weight loss
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals ... that promote and preserve muscle during weight loss. This approach is based on the understanding that muscle preservation is crucial for overall ...
Nasdaq6d
Regeneron Acquires Rights to HS-20094 from Hansoh Pharma to Enhance Obesity and Metabolic Treatment Pipeline
Regeneron's obesity research includes the Phase 2 COURAGE study, investigating new combinations with semaglutide and targeting muscle preservation during weight loss. Disclaimer: This is an AI ...
Investing6d
Truist Securities maintains buy rating on Regeneron stock
Additionally, interim results from Regeneron’s Phase 2 COURAGE trial showed that combining semaglutide with muscle-preserving antibodies improved muscle preservation and fat loss compared to ...